|
SE0100567D0
(sv)
*
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
|
AU2002364889A1
(en)
*
|
2001-09-24 |
2003-06-10 |
University Of Aarhus |
Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
|
|
DK1467761T3
(da)
*
|
2001-11-30 |
2007-02-05 |
Quadra Logic Tech Inc |
Behandling af neovaskulære oftalmiske sygdomme
|
|
CN1281606C
(zh)
|
2002-03-01 |
2006-10-25 |
安斯泰来制药有限公司 |
含氮杂环化合物
|
|
AU2003255845A1
(en)
*
|
2002-08-22 |
2004-03-11 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
|
BRPI0414171A
(pt)
*
|
2003-09-04 |
2006-10-31 |
Warner Lambert Co |
benzo[b]tiofenos halossubstituìdos com atividade inibidora de pi3k como agentes terapêuticos
|
|
ES2287896T3
(es)
*
|
2004-01-12 |
2007-12-16 |
Laboratoires Serono Sa |
Derivados de tiazol y uso de los mismos.
|
|
CA2577478A1
(en)
*
|
2004-08-18 |
2006-02-23 |
Pharmacia & Upjohn Company Llc |
Triazolopyridine compounds
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
BRPI0517253A
(pt)
*
|
2004-10-28 |
2008-10-07 |
Irm Llc |
compostos e composições como moduladores de trajetória de ouriço
|
|
US8030327B2
(en)
|
2004-11-08 |
2011-10-04 |
Mds K.K. |
Fused imidazole derivative
|
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
|
CA2663528A1
(en)
*
|
2006-09-18 |
2008-03-27 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic inhibitors of c-met and uses thereof
|
|
MX2009004623A
(es)
*
|
2006-10-30 |
2009-05-15 |
Novartis Ag |
Imidazopiridazinas como inhibidores de la lipido cinasa pi3k.
|
|
EP1972631A1
(de)
*
|
2007-03-23 |
2008-09-24 |
Novartis AG |
Imidazopyridazine als PI3K-Lipidkinaseinhibitoren
|
|
EA201300152A1
(ru)
|
2006-11-27 |
2013-07-30 |
Х. Лундбекк А/С |
Гетероариламидные производные
|
|
AR064106A1
(es)
*
|
2006-12-05 |
2009-03-11 |
Bayer Schering Pharma Ag |
Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida utiles para el tratamiento de enfermedades y trastornos hiper-proliferativos asociados con la angiogenesis
|
|
CN101502484B
(zh)
*
|
2006-12-26 |
2011-04-20 |
济南康泉医药科技有限公司 |
同载糖皮质激素和化疗药物的抗癌缓释剂
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
CN101657430B
(zh)
|
2007-03-15 |
2013-05-01 |
诺瓦提斯公司 |
有机化合物及其用途
|
|
WO2008124323A1
(en)
|
2007-04-03 |
2008-10-16 |
Array Biopharma Inc. |
Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
|
|
BRPI0809567A2
(pt)
|
2007-04-10 |
2014-09-23 |
Lundbeck & Co As H |
Composto, composição farmacêutica, método para modular a atividade de um receptor de p2x7, para tratar uma condição responsiva à modulação do receptor de p2x7 em um paciente, para inibir a morte de células do gânglio retinal em um paciente, e para determinar a presença ou ausência do receptor de p2x7 em uma amostra, preparação farmacêutica acondiciaonada, e, uso de um composto
|
|
EP2142551B1
(de)
|
2007-04-17 |
2015-10-14 |
Bristol-Myers Squibb Company |
KONDENSIERTE HETEROCYCLISCHE Verbindungen als Hemmer der BETA-HYDROXYSTEROID-DEHYDROGENASE -TYP I
|
|
KR20100019489A
(ko)
*
|
2007-05-09 |
2010-02-18 |
노파르티스 아게 |
Ｐｉ３ｋ 지질 키나제 억제제로서의 치환된 이미다조피리다진
|
|
AU2008253311A1
(en)
*
|
2007-05-18 |
2008-11-27 |
Bayer Schering Pharma Aktiengesellshaft |
Inhibitors of hypoxia inducible factor (HIF) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
|
|
PA8793301A1
(es)
*
|
2007-08-14 |
2009-04-23 |
Bayer Schering Pharma Ag |
Imidazoles bicíclicos fusionados
|
|
EP2062893A1
(de)
*
|
2007-10-18 |
2009-05-27 |
Bayer Schering Pharma AG |
Fusionierte Imidazole zur Behandlung von Krebs
|
|
AU2008297876B2
(en)
|
2007-09-14 |
2011-07-07 |
Addex Pharma S.A. |
1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
|
|
CN103342695B
(zh)
|
2007-09-14 |
2015-04-22 |
杨森制药有限公司 |
1’,3’-二取代的-4-苯基-3,4,5,6-四氢-2h,1’h-[1,4’]二吡啶-2’-酮
|
|
EP2060565A1
(de)
|
2007-11-16 |
2009-05-20 |
4Sc Ag |
Neue bifunktionelle Verbindungen die Proteinkinasen und Histonedeacetylasen hemmen
|
|
CN101952285A
(zh)
*
|
2007-11-27 |
2011-01-19 |
塞尔卓姆有限公司 |
作为pi3k抑制剂的氨基***
|
|
WO2009100375A1
(en)
|
2008-02-06 |
2009-08-13 |
Bristol-Myers Squibb Company |
Substituted imidazopyridazines useful as kinase inhibitors
|
|
AR070487A1
(es)
|
2008-02-28 |
2010-04-07 |
Novartis Ag |
Derivados de 3- metil- imidazo -( 1,2-b)- piridazina
|
|
WO2009126861A2
(en)
|
2008-04-11 |
2009-10-15 |
Bristol-Myers Squibb Company |
Triazolopyridine compounds useful as dgat1 inhibitors
|
|
US8324241B2
(en)
|
2008-04-11 |
2012-12-04 |
Bristol-Myers Squibb Company |
Triazolo compounds useful as DGAT1 inhibitors
|
|
JP5640005B2
(ja)
|
2008-07-14 |
2014-12-10 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｈｄａｃおよび／またはｃｄｋ阻害剤としてのイミダゾシルピリジン化合物
|
|
EP2303841A1
(de)
|
2008-07-14 |
2011-04-06 |
Gilead Sciences, Inc. |
Oxindolylhemmerverbindungen
|
|
JP5640006B2
(ja)
|
2008-07-14 |
2014-12-10 |
ギリアード サイエンシーズ， インコーポレイテッド |
ヒストン脱アセチル化酵素および／またはサイクリン依存性キナーゼの縮合複素環式阻害剤
|
|
WO2010007099A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Cellzome Limited |
2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors
|
|
US20100041663A1
(en)
|
2008-07-18 |
2010-02-18 |
Novartis Ag |
Organic Compounds as Smo Inhibitors
|
|
BRPI0916713A2
(pt)
|
2008-07-28 |
2015-11-10 |
Gilead Science Inc |
compostos inibidores de histona desacetilase de cicloalquilideno e heterocicloalquilideno
|
|
US8557809B2
(en)
|
2008-08-19 |
2013-10-15 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為ｐｉｍ激酶抑制劑之***吡啶化合物
|
|
US8895550B2
(en)
|
2008-08-19 |
2014-11-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
US8987251B2
(en)
|
2008-08-19 |
2015-03-24 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
BRPI0918055A2
(pt)
|
2008-09-02 |
2015-12-01 |
Addex Pharmaceuticals Sa |
derivados de 3-azabiciclo[3,1,0]hexila como moduladores de receptores metabotrópicos de glutamato.
|
|
TWI491610B
(zh)
|
2008-10-09 |
2015-07-11 |
必治妥美雅史谷比公司 |
作為激酶抑制劑之咪唑并嗒腈
|
|
MX2011005242A
(es)
|
2008-11-28 |
2011-09-06 |
Ortho Mcneil Janssen Pharm |
Derivados de indol y benzoxazina como moduladores de los receptores de glutamato metabotropicos.
|
|
WO2010074586A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Pathway Therapeutics Limited |
Pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine derivatives and their use in cancer therapy
|
|
EP2417135A1
(de)
|
2009-04-07 |
2012-02-15 |
Schering Corporation |
Substituierte triazolopyridine und analoga davon
|
|
MY161325A
(en)
|
2009-05-12 |
2017-04-14 |
Janssen Pharmaceuticals Inc |
1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
|
|
AR076859A1
(es)
|
2009-05-12 |
2011-07-13 |
Ortho Mcneil Janssen Pharm |
Derivados de 1,2,4-triazolo[4,3-a]piridina moduladores alostericos positivos de receptores mglur2 , composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos neurologicos y siquiatricos.
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
ES2463826T3
(es)
|
2009-06-08 |
2014-05-29 |
Gilead Sciences, Inc. |
Compuestos inhibidores de HDAC de cicloalquilcarbamato benzamida anilina
|
|
BRPI1010884A2
(pt)
|
2009-06-08 |
2016-03-15 |
Gilead Sciences Inc |
composto inibidores hdac de alcanoilamino benzamida anilina
|
|
US8389526B2
(en)
|
2009-08-07 |
2013-03-05 |
Novartis Ag |
3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
|
|
BR112012003262A8
(pt)
|
2009-08-12 |
2016-05-17 |
Novartis Ag |
compostos de hidrazona heterocíclica e seus usos para tratar câncer e inflamação
|
|
KR20120089463A
(ko)
|
2009-08-20 |
2012-08-10 |
노파르티스 아게 |
헤테로시클릭 옥심 화합물
|
|
US9309238B2
(en)
|
2009-11-05 |
2016-04-12 |
University Of Notre Dame Du Lac |
Imidazo [1,2-a]pyridine compounds, synthesis thereof, and methods of using same
|
|
EP2496577A1
(de)
*
|
2009-11-06 |
2012-09-12 |
Piramal Life Sciences Limited |
Imidazopyridinderivate
|
|
ES2531109T3
(es)
*
|
2009-12-30 |
2015-03-10 |
Arqule Inc |
Compuestos de imidazopiridinil-aminopiridina
|
|
CN102971326A
(zh)
|
2010-04-28 |
2013-03-13 |
百时美施贵宝公司 |
咪唑并哒嗪化合物及其在癌症中的用途
|
|
TWI541243B
(zh)
|
2010-09-10 |
2016-07-11 |
拜耳知識產權公司 |
經取代咪唑并嗒
|
|
ES2552879T3
(es)
|
2010-11-08 |
2015-12-02 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
|
WO2012062750A1
(en)
|
2010-11-08 |
2012-05-18 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
|
ES2536433T3
(es)
|
2010-11-08 |
2015-05-25 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
|
US20120129872A1
(en)
*
|
2010-11-18 |
2012-05-24 |
Kristi Anne Leonard |
Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation
|
|
CN106986862A
(zh)
|
2010-12-22 |
2017-07-28 |
Abbvie 公司 |
丙型肝炎抑制剂及其用途
|
|
CN102030752A
(zh)
*
|
2011-01-06 |
2011-04-27 |
贵阳中医学院 |
一种制备化合物2-(咪唑并[1,2-a]吡啶-3-基)乙腈的方法
|
|
KR20140048079A
(ko)
|
2011-02-01 |
2014-04-23 |
교와 핫꼬 기린 가부시키가이샤 |
축환 복소환 유도체
|
|
US8889704B2
(en)
|
2011-02-25 |
2014-11-18 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
|
ES2558780T3
(es)
|
2011-04-07 |
2016-02-08 |
Bayer Intellectual Property Gmbh |
Imidazopiridazinas como inhibidores de la cinasa Akt
|
|
WO2012156379A1
(en)
*
|
2011-05-13 |
2012-11-22 |
Universität Zürich |
PIK3/P110α INHIBITORS FOR PREVENTION OF RESTENOSIS BY APPLICATION AS AN IMPLANT COATING
|
|
KR101274986B1
(ko)
*
|
2011-07-27 |
2013-06-17 |
한국과학기술원 |
이미다조피리딘 유도체, 이를 포함하는 ＰＩ3Ｋ 및/또는 ｍＴＯＲ 저해제용 약학 조성물 및 ＰＩ3Ｋ 및/또는 ｍＴＯＲ과 연관된 질환 치료용 약학 조성물
|
|
JP6193233B2
(ja)
|
2012-07-31 |
2017-09-06 |
協和発酵キリン株式会社 |
縮環複素環化合物
|
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
|
US8778964B2
(en)
|
2012-11-05 |
2014-07-15 |
Bayer Pharma Aktiengesellschaft |
Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
|
|
US8796305B2
(en)
|
2012-11-05 |
2014-08-05 |
Bayer Pharma Aktiengesellschaft |
Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
|
US9126998B2
(en)
|
2012-11-05 |
2015-09-08 |
Bayer Pharma AG |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
|
BR112015012571B1
(pt)
*
|
2012-11-30 |
2022-05-24 |
Astellas Pharma Inc |
Compostos de imidazopiridina e usos terapêuticos dos mesmos
|
|
JP6505023B2
(ja)
|
2013-02-19 |
2019-04-24 |
ファイザー・インク |
Ｃｎｓおよび他の障害を治療するための、ｐｄｅ４アイソザイムの阻害薬としてのアザベンゾイミダゾール化合物
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
US9776997B2
(en)
|
2013-06-04 |
2017-10-03 |
Bayer Pharma Aktiengesellschaft |
3-aryl-substituted imidazo[1,2-A]pyridines and their use
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
CN106061504B
(zh)
|
2014-01-21 |
2019-09-06 |
詹森药业有限公司 |
包括代谢型谷氨酸能受体亚型2的正别构调节物或正位激动剂的组合及其用途
|
|
KR20200126026A
(ko)
|
2014-01-21 |
2020-11-05 |
얀센 파마슈티카 엔.브이. |
대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
|
|
TWI720451B
(zh)
|
2014-02-13 |
2021-03-01 |
美商英塞特控股公司 |
作為lsd1抑制劑之環丙胺
|
|
ES2760261T3
(es)
|
2014-02-13 |
2020-05-13 |
Incyte Corp |
Ciclopropilaminas como inhibidores de LSD1
|
|
WO2015123437A1
(en)
|
2014-02-13 |
2015-08-20 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
WO2015123408A1
(en)
|
2014-02-13 |
2015-08-20 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
JP2017507140A
(ja)
|
2014-02-19 |
2017-03-16 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
３−（ピリミジン−２−イル）イミダゾ［１，２−ａ］ピリジン
|
|
CA2943005A1
(en)
|
2014-03-21 |
2015-09-24 |
Bayer Pharma Aktiengesellschaft |
Cyano-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
|
MX367267B
(es)
*
|
2014-03-24 |
2019-08-12 |
Arqule Inc |
Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina.
|
|
US9422283B2
(en)
*
|
2014-04-22 |
2016-08-23 |
Arqule, Inc. |
Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compound
|
|
JP2017514898A
(ja)
|
2014-05-02 |
2017-06-08 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
心血管疾患の治療のためのｎ−（２−アミノ−５−フルオロ−２−メチルペンチル）−８−［（２，６−ジフルオロベンジル）オキシ］−２−メチルイミダゾ［１，２−ａ］ピリジン−３−カルボキサミドの、並びにジ−及びトリフルオロ誘導体のエナンチオマー
|
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
TWI687419B
(zh)
|
2014-07-10 |
2020-03-11 |
美商英塞特公司 |
作為ｌｓｄ１抑制劑之咪唑并吡啶及咪唑并吡嗪
|
|
US9695180B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
|
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
|
US10131669B2
(en)
|
2014-07-24 |
2018-11-20 |
Pfizer Inc. |
Pyrazolopyrimidine compounds
|
|
KR102061952B1
(ko)
|
2014-08-06 |
2020-01-02 |
화이자 인코포레이티드 |
이미다조피리다진 화합물
|
|
WO2016087343A1
(de)
|
2014-12-02 |
2016-06-09 |
Bayer Pharma Aktiengesellschaft |
Heteroaryl-substituierte imidazo[1,2-a]pyridine und ihre verwendung
|
|
SG11201708047UA
(en)
|
2015-04-03 |
2017-10-30 |
Incyte Corp |
Heterocyclic compounds as lsd1 inhibitors
|
|
WO2017027678A1
(en)
|
2015-08-12 |
2017-02-16 |
Incyte Corporation |
Salts of an lsd1 inhibitor
|
|
PE20181352A1
(es)
|
2015-09-17 |
2018-08-22 |
Marvin J Miller |
Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias
|
|
GB201602527D0
(en)
*
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
CN107304202A
(zh)
*
|
2016-04-20 |
2017-10-31 |
苏州苏领生物医药有限公司 |
五元杂环类化合物及其制备方法、药物组合物和用途
|
|
WO2017181973A1
(zh)
*
|
2016-04-20 |
2017-10-26 |
苏州苏领生物医药有限公司 |
五元杂环类化合物及其制备方法、药物组合物和用途
|
|
TWI833686B
(zh)
|
2016-04-22 |
2024-03-01 |
美商英塞特公司 |
Lsd1 抑制劑之調配物
|
|
EP3454852A4
(de)
|
2016-05-11 |
2020-02-26 |
Emory University |
Phosphotidylinositol-3-kinase-inhibitoren
|
|
US11352328B2
(en)
|
2016-07-12 |
2022-06-07 |
Arisan Therapeutics Inc. |
Heterocyclic compounds for the treatment of arenavirus
|
|
WO2018184976A1
(de)
|
2017-04-05 |
2018-10-11 |
Bayer Pharma Aktiengesellschaft |
Substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung
|
|
AU2018354785A1
(en)
|
2017-10-24 |
2020-04-23 |
Bayer Aktiengesellschaft |
Substituted imidazopyridine amides and use thereof
|
|
WO2020047198A1
(en)
|
2018-08-31 |
2020-03-05 |
Incyte Corporation |
Salts of an lsd1 inhibitor and processes for preparing the same
|
|
JP2022526901A
(ja)
|
2019-03-19 |
2022-05-27 |
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド |
駆虫性アザベンゾチオフェンおよびアザベンゾフラン化合物
|
|
WO2020216669A1
(de)
|
2019-04-23 |
2020-10-29 |
Bayer Aktiengesellschaft |
Phenylsubstituierte imidazopyridinamide und ihre verwendung
|
|
US20230174470A1
(en)
*
|
2020-04-27 |
2023-06-08 |
Autotac Inc. |
Compound as a ubr box domain ligand
|
|
EP4185589A1
(de)
|
2020-05-29 |
2023-05-31 |
Boehringer Ingelheim Animal Health USA Inc. |
Anthelmintische heterocyclische verbindungen
|
|
CN113135913B
(zh)
*
|
2021-04-28 |
2022-05-24 |
沈阳药科大学 |
3-取代基-6-吡啶类取代基-六元并五元杂环类衍生物及其制法与用途
|
|
TW202333665A
(zh)
|
2021-11-01 |
2023-09-01 |
德商百靈佳殷格翰維美迪加股份有限公司 |
驅蟲吡咯幷嗒𠯤化合物
|